RSS   Newsletter   Contact   Advertise with us

PrimeraDx names Matthew F. McManus president and CEO

Staff writer | Mansfield, Mass., USA | August 30, 2010
PrimeraDxAugust 30, 2010, Mansfield, Mass., USA - PrimeraDx, a molecular diagnostics company, announced that Matthew F. McManus has been appointed president and chief executive officer, effective immediately.
Dr. McManus joined PrimeraDx in August 2010 from his prior position as Head of Cleveland Clinic Laboratories (CCL) and Chief Operating Officer of the Pathology and Laboratory Medicine Institute. In his three years in Cleveland he successfully expanded the Clinic's reference laboratory services and secured funding for construction of a major new laboratory facility.

Prior to leading CCL, he was the Medical Scientist for the Novartis Institutes for Biomedical Research Drug Discovery Incubator, where he helped found the External Fast Follower group. He has also worked at McKinsey & Company, consulting for diagnostics, device and other health care clients, and at Procter & Gamble in sales and marketing.

He received his MD and Ph.D. from the University of Pennsylvania School of Medicine, his MBA from Boston College, and his BA from the College of the Holy Cross. Dr. McManus has also been appointed to the Company's Board of Directors.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST